Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 125
Filter
1.
Am J Nephrol ; 39(1): 20-6, 2014.
Article in English | MEDLINE | ID: mdl-24401699

ABSTRACT

BACKGROUND: BK virus (BKV) is an important cause of renal dysfunction in kidney transplant (KTX) recipients. Immunosuppression intensity is a major risk factor for BKV replication in these patients. The prevalence of BKV replication in immunosuppressed patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) without transplant is not known. METHODS: Consecutive patients (n = 37) with a diagnosis of GPA (n = 25) or MPA (n = 12) without history of KTX were evaluated for plasma BKV replication by quantitative PCR (group A). Descriptive data were collected. BKV replication in this nontransplant immunosuppressed vasculitis cohort was compared with a historical cohort of vasculitis KTX recipients (group B). RESULTS: Group A patients had mean disease duration of 75 months. Mean age was 57 years and 54% were female. Mean time from vasculitis onset to BKV testing was 36 months, and 19/37 patients were tested within 24 months of induction therapy. At the time of BKV testing, 73% were on prednisone (P) with azathioprine, mycophenolate mofetil (MMF), methotrexate or leflunomide. None of the nontransplanted vasculitis patients had detectable plasma BKV. Among 35 patients in group B, 16 were tested for BKV; 5/16 (31%) had detectable virus in plasma at a mean of 6 months after TX (p = 0.002). Most (94%) were on maintenance therapy with MMF, P and tacrolimus. CONCLUSION: Immunosuppressed patients with GPA/MPA without KTX had no evidence of plasma BKV. However, BKV was common in GPA/MPA patients after KTX, suggesting that replication may be related to differences in immunosuppression, alloimmune activation or differences in host defense mechanisms.


Subject(s)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/blood , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/virology , BK Virus/physiology , Polyomavirus Infections/diagnosis , Adult , Aged , Cohort Studies , Cross-Sectional Studies , Female , Humans , Immunosuppressive Agents/adverse effects , Male , Middle Aged , Polymerase Chain Reaction , Retrospective Studies , Risk Factors , Virus Replication
2.
Calcif Tissue Int ; 93(5): 472-80, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23979114

ABSTRACT

Intracortical microstructure influences crack propagation and arrest within bone cortex. Genetic variation in intracortical remodeling may contribute to mechanical integrity and, therefore, fracture risk. Our aim was to determine the degree to which normal population-level variation in intracortical microstructure is due to genetic variation. We examined right femurs from 101 baboons (74 females, 27 males; aged 7-33 years) from a single, extended pedigree to determine osteon number, osteon area (On.Ar), haversian canal area, osteon population density, percent osteonal bone (%On.B), wall thickness (W.Th), and cortical porosity (Ct.Po). Through evaluation of the covariance in intracortical properties between pairs of relatives, we quantified the contribution of additive genetic effects (heritability [h (2)]) to variation in these traits using a variance decomposition approach. Significant age and sex effects account for 9 % (Ct.Po) to 21 % (W.Th) of intracortical microstructural variation. After accounting for age and sex, significant genetic effects are evident for On.Ar (h (2) = 0.79, p = 0.002), %On.B (h (2) = 0.82, p = 0.003), and W.Th (h (2) = 0.61, p = 0.013), indicating that 61-82 % of the residual variation (after accounting for age and sex effects) is due to additive genetic effects. This corresponds to 48-75 % of the total phenotypic variance. Our results demonstrate that normal, population-level variation in cortical microstructure is significantly influenced by genes. As a critical mediator of crack behavior in bone cortex, intracortical microstructural variation provides another mechanism through which genetic variation may affect fracture risk.


Subject(s)
Bone Density/genetics , Bone Remodeling/genetics , Genes/physiology , Age Factors , Animals , Female , Femur/ultrastructure , Genetic Predisposition to Disease , Male , Observer Variation , Osteoporosis/genetics , Papio , Porosity , Sex Factors
3.
Osteoarthritis Cartilage ; 21(6): 839-48, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23499674

ABSTRACT

OBJECTIVE: We aimed to characterize severity and occurrence of knee osteoarthritis (OA), and effects of age, sex, body mass, and reproductive status on population-level normal variation in this condition in the baboon, a natural model of human knee OA. METHODS: We visually inspected articular cartilage of distal right femora of 464 baboons (309 females, 155 males) and assigned an OA severity score (comparable to a modified Outerbridge score) from 1 = unaffected to 4 = advanced OA (eburnation). Presence/absence of osteophytes was recorded. We tested for significant effects of age, sex, body mass, and, in females, reproductive status (pre-, peri-, or post-menopausal) on OA. When appropriate, analyses were repeated on an age-matched subset (153 of each sex). RESULTS: Knee OA was more frequent and severe in older animals (P < 0.0001), but significant age variation was apparent in each severity grade. Sex differences within the younger and older age groups suggest that males develop knee OA earlier, but females progress more quickly to advanced disease. There is a strong relationship between reproductive status and OA severity grade in females (P = 0.0005) with more severe OA in peri- and post-menopausal female baboons, as in humans. CONCLUSIONS: Idiopathic knee OA is common in adult baboons. Occurrence and severity are influenced strongly by reproductive status in females, and by sex with regard to patterns of disease progression - providing an animal model to investigate sex-specific variation in OA susceptibility in which the environmental heterogeneity inherent in human populations is vastly reduced.


Subject(s)
Osteoarthritis, Knee/epidemiology , Age Factors , Animals , Body Weight , Disease Progression , Female , Male , Osteoarthritis, Knee/diagnostic imaging , Osteoarthritis, Knee/metabolism , Osteophyte/diagnostic imaging , Osteophyte/metabolism , Papio , Radiography , Retrospective Studies , Risk Factors , Sex Factors
4.
Am J Transplant ; 9(9): 2085-91, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19645709

ABSTRACT

Invasive fungal infections (IFI) are common after lung transplantation and there are limited data for the use of antifungal prophylaxis in these patients. Our aim was to compare the safety and describe the effectiveness of universal prophylaxis with two azole regimens in lung transplant recipients. This is a retrospective study in lung transplant recipients from July 2003 to July 2006 who received antifungal prophylaxis with itraconazole or voriconazole plus inhaled amphotericin B to compare the incidence of hepatotoxicity. Secondary outcomes include describing the incidence of IFI, clinical outcomes after IFI and mortality. Sixty-seven consecutive lung transplants received antifungal prophylaxis, 32 itraconazole and 35 voriconazole and inhaled amphotericin B. There were no significant differences between groups in the acute physiology and chronic health evaluation (APACHE) score at the time of transplantation, demographic characteristics, comorbidities and concomitant use of hepatotoxic medications. Hepatotoxicity occurred in 12 patients receiving voriconazole and inhaled amphotericin B and in no patients receiving itraconazole (p < 0.001). There was no significant difference between groups with regard to the percentage of transplants with IFI, but one case of zygomycosis occurred in a transplant treated with voriconazole. Voriconazole prophylaxis after lung transplantation was associated with a higher incidence of hepatotoxicity and similar clinical effectiveness when compared to itraconazole.


Subject(s)
Antifungal Agents/therapeutic use , Itraconazole/therapeutic use , Lung Transplantation/methods , Mycoses/complications , Mycoses/prevention & control , Pyrimidines/therapeutic use , Triazoles/therapeutic use , Aged , Cohort Studies , Female , Humans , Lung Diseases, Fungal , Male , Middle Aged , Postoperative Complications , Retrospective Studies , Treatment Outcome , Voriconazole
5.
J Med Primatol ; 37(3): 146-53, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18642436

ABSTRACT

BACKGROUND: Little is known about the degree to which baboons, an important animal model in skeletal research, spontaneously experience age-related osteopenia and osteoporosis. METHODS: We measured bone mineral density (BMD) in 667 baboons, assigned T-scores to older animals based on sex-specific young adult reference groups, and compared reproductive history in older females with low BMD to those with normal BMD. RESULTS: Approximately 25% of older baboon females were osteopenic. No females or males were osteoporotic. Neither parity nor interbirth interval spine clearly distinguished low vs. normal BMD groups. Intersite correspondence in low BMD was highest between sites in the same region rather than sites of the same bone type. CONCLUSION: As with humans, osteopenia is common among older females. The absence of osteoporotic animals may be due to colony maintenance resulting in truncation of the aged population and selection for healthier animals in the oldest ranges.


Subject(s)
Bone Diseases, Metabolic/veterinary , Monkey Diseases/pathology , Osteoporosis/veterinary , Papio hamadryas , Aging , Animals , Bone Density/physiology , Female , Male
6.
Mult Scler ; 13(9): 1118-26, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17967839

ABSTRACT

The iron chelator, Desferal, suppressed disease activity of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS), and it has been tested in pilot trials for MS. The administration regimen of Desferal is cumbersome and prone to complications. Orally-deliverable, iron chelators have been developed that circumvent these difficulties, and the objective of this study was to test an oral chelator in EAE. SJL mice with active EAE were randomly assigned to receive deferiprone (150 mg/kg) or vehicle (water) 2x/day via gavage. EAE mice given deferiprone had significantly less disease activity and lower levels of inflammatory cell infiltrates (revealed by H&E staining) than EAE mice administered vehicle. T-cell infiltration, assessed by anti-CD3 immunohistochemical staining, also was reduced, although not significantly. Splenocytes cultured from naïve SJL mice were stimulated with anti-CD3 and anti-CD28 with or without 250 microM deferiprone. While approximately 39% of costimulated splenocytes without deferiprone underwent division, only approximately 2.8% of costimulated splenocytes with deferiprone divided and the latter cells were only 53% as viable as the former. Deferiprone had no effect on proliferation or viability of cells that were not costimulated. In summary, deferiprone effectively suppressed active EAE disease and it inhibited T-cell function.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/drug therapy , Iron Chelating Agents/pharmacology , Pyridones/pharmacology , Administration, Oral , Animals , Cell Division/drug effects , Cell Division/immunology , Deferiprone , Encephalomyelitis, Autoimmune, Experimental/immunology , Encephalomyelitis, Autoimmune, Experimental/pathology , Female , Mice , Mice, Inbred Strains , Severity of Illness Index , Spleen/pathology , T-Lymphocytes/pathology
7.
Antimicrob Agents Chemother ; 48(9): 3498-507, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15328117

ABSTRACT

Entecavir (ETV) exhibits potent antiviral activity in patients chronically infected with wild-type or lamivudine (3TC)-resistant (3TC(r)) hepatitis B virus (HBV). Among the patients treated in phase II ETV clinical trials, two patients for whom previous therapies had failed exhibited virologic breakthrough while on ETV. Isolates from these patients (arbitrarily designated patients A and B) were analyzed genotypically for emergent substitutions in HBV reverse transcriptase (RT) and phenotypically for reduced susceptibility in cultures and in HBV polymerase assays. After 54 weeks of 3TC therapy, patient A (AI463901-A) received 0.5 mg of ETV for 52 weeks followed by a combination of ETV and 100 mg of 3TC for 89 weeks. Viral rebound occurred at 133 weeks after ETV was started. The 3TC(r) RT substitutions rtV173L, rtL180M, and rtM204V were present at study entry, and the additional substitutions rtI169T and rtM250V emerged during ETV-3TC combination treatment. Reduced ETV susceptibility in vitro required the rtM250V substitution in addition to the 3TC(r) substitutions. For liver transplant patient B (AI463015-B), previous famciclovir, ganciclovir, foscarnet, and 3TC therapies had failed, and RT changes rtS78S/T, rtV173L, rtL180M, rtT184S, and rtM204V were present at study entry. Viral rebound occurred after 76 weeks of therapy with ETV at 1.0 mg, with the emergence of rtT184G, rtI169T, and rtS202I substitutions within the preexisting 3TC(r) background. Reduced susceptibility in vitro was highest when both the rtT184G and the rtS202I changes were combined with the 3TC(r) substitutions. In summary, infrequent ETV resistance can emerge during prolonged therapy, with selection of additional RT substitutions within a 3TC(r) HBV background, leading to reduced ETV susceptibility and treatment failure.


Subject(s)
Antiviral Agents/pharmacology , Guanine/analogs & derivatives , Guanine/pharmacology , Hepatitis B virus/drug effects , Hepatitis B virus/genetics , Lamivudine/pharmacology , Reverse Transcriptase Inhibitors/pharmacology , Adult , Amino Acid Substitution/genetics , Antiviral Agents/therapeutic use , Capsid Proteins/biosynthesis , Capsid Proteins/genetics , Cell Line, Tumor , Cells, Cultured , DNA-Directed DNA Polymerase/genetics , Drug Resistance, Viral , Genotype , Guanine/therapeutic use , Hepatitis B/drug therapy , Hepatitis B/virology , Hepatitis B virus/enzymology , Humans , Lamivudine/therapeutic use , Male , Middle Aged , Mutation , Phenotype , RNA-Directed DNA Polymerase/genetics , Reverse Transcriptase Inhibitors/therapeutic use , Treatment Failure , Virus Replication/drug effects , Virus Replication/genetics
8.
Cell Mol Biol (Noisy-le-grand) ; 49(5): 723-32, 2003 Jul.
Article in English | MEDLINE | ID: mdl-14528908

ABSTRACT

Experimental allergic encephalomyelitis (EAE) is an autoimmune disease characterized by demyelination and inflammatory infiltrates in the CNS, and it is an animal model of multiple sclerosis. Piperonyl butoxide (PBO) suppresses disease in EAE mice, and it exhibits a dual effect on cytochrome P450s that manifests in a transient inhibitory phase followed by induction. In order to identify the expression of proteins associated with EAE, a proteomic screening was performed on hindbrain microsomes from control + vehicle, control + PBO, EAE + vehicle, and EAE + PBO female mice. Glucose regulated protein 94 (Grp94) and coagulation factor VIII were among the proteins identified in EAE + vehicle and EAE + PBO mice. Immunohistochemical staining of Grp94 was present in some neurons and oligodendrocytes in hindbrain sections from control animals, and in some cells within inflammatory infiltrates in EAE animals. Since Grp94 (also known as Gp96) can partake in antigen presentation and induction of proinflammatory cytokine expression, its presence in these cells suggests that it may play a role in the pathogenesis of EAE. Coagulation factor VIII is carried and protected by von Willebrand factor. Immunohistochemical staining of von Willebrand factor revealed its presence in some vessels within hindbrain sections from control animals. In EAE animals, the number of labeled vessels was significantly increased, and extracellular granular deposits were observed around labeled vessels indicating that the breakdown of the blood-brain barrier that occurs in EAE permitted its extravasation into the CNS. Additional proteins were identified in the different groups of mice by proteomic screening, but confirmation of their expression profile awaits investigations by independent measures.


Subject(s)
Central Nervous System/chemistry , Encephalomyelitis, Autoimmune, Experimental/metabolism , Proteome/analysis , Animals , Antigens, Neoplasm/analysis , Central Nervous System/drug effects , Central Nervous System/pathology , Databases, Protein , Electrophoresis, Polyacrylamide Gel , Encephalomyelitis, Autoimmune, Experimental/chemically induced , Encephalomyelitis, Autoimmune, Experimental/pathology , Female , Hydrolysis , Image Processing, Computer-Assisted , Immunohistochemistry , Medulla Oblongata/chemistry , Mice , Microsomes/chemistry , Myelin Proteolipid Protein/pharmacology , Peptide Fragments/pharmacology , Peptide Mapping/methods , Pertussis Toxin/pharmacology , Piperonyl Butoxide/pharmacology , Pons/chemistry , Proteome/isolation & purification , Rhombencephalon/chemistry , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Trypsin/metabolism , von Willebrand Factor/analysis
9.
Cell Mol Biol (Noisy-le-grand) ; 49(5): 779-87, 2003 Jul.
Article in English | MEDLINE | ID: mdl-14528915

ABSTRACT

Globoid cell leukodystrophy (Krabbe disease) is caused by mutations in galactosylceramidase, a lysosomal enzyme that acts to digest galactosylceramide, a glycolipid concentrated in myelin, and psychosine (galactosylsphingosine). Globoid cell leukodystrophy has been identified in many species including humans and twitcher mice. Several studies on human tissue have examined the lipid profile in this disease by gas, liquid or thin layer chromatography. Electrospray ionization tandem mass spectrometry combined with reverse phase HPLC has become a powerful alternative strategy, used here to compare the sphingolipid profile of pons/medulla tissue from twitcher mice with control tissue. In this lipidomics LC-MS approach, we scanned for precursors of m/z 264 to obtain a semi-quantitative profile of ceramides and galactosylceramides. Sphingosine-1-phosphate, C18:0 ceramide, C22:0 ceramide and C24:0 ceramide levels were reduced in the pons/medulla of twitcher mice compared to levels in control mice at 31 and 35-37 days of age. The levels of C22:0 and C24:0 galactosylceramide were similar between twitcher and control specimens and there was a trend toward reduced levels of C24:1 galactosylceramide and C24:1 hydroxy-galactosylceramide in twitcher specimens. Psychosine, C 16:0 ceramide and C 18:0 galactosylceramide levels were increased in the CNS of twitcher mice compared to levels in control mice. These data indicate that there is a trend toward decreased levels of long chain fatty acids and increased levels of shorter chain fatty acids in galactosylceramides and ceramides from twitcher mice compared with control mice, and such changes may be due to demyelination characteristic of acute pathology.


Subject(s)
Central Nervous System/chemistry , Leukodystrophy, Globoid Cell/metabolism , Sphingolipids/analysis , Animals , Central Nervous System/physiopathology , Ceramides/analysis , Chromatography, High Pressure Liquid , Chromatography, Liquid , Disease Models, Animal , Fatty Acids/analysis , Galactosylceramides/analysis , Leukodystrophy, Globoid Cell/physiopathology , Lysophospholipids/analysis , Mass Spectrometry , Medulla Oblongata/chemistry , Medulla Oblongata/physiopathology , Mice , Mice, Inbred C57BL , Mice, Neurologic Mutants , Pons/chemistry , Pons/physiopathology , Psychosine/analysis , Sphingolipids/chemistry , Sphingolipids/isolation & purification , Sphingosine/analogs & derivatives , Sphingosine/analysis
10.
Mult Scler ; 9(4): 372-81, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12926842

ABSTRACT

The expression of heme oxygenase-1 (HO-1) is increased in the CNS of mice and rats with experimental allergic encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). To investigate the role of HO-1 in EAE, a putative inhibitor [tin-protoporphyrin IX (Sn-PP IX)] of HO-1 was administered to SJL mice during active disease. Sn-PP IX (200 micromol/kg) attenuated clinical scores, weight loss, and some signs of pathology in comparison to vehicle treatment. Glutathione levels were greater in treated EAE mice than in those receiving vehicle, indicating lower oxidative stress in the former group. These data suggest that inhibition of HO-1 attenuated disease and suppressed free radical production. In the SJL model of EAE, extravasated blood is present in the CNS, and iron released by HO-1 from this heme source may not be adequately sequestered by ferritin, allowing for iron-mediated tissue damage. Thus, HO-1 may act to amplify the disease process in this model.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/metabolism , Heme Oxygenase (Decyclizing)/metabolism , Animals , Brain/cytology , Brain/enzymology , Brain/pathology , Encephalomyelitis, Autoimmune, Experimental/pathology , Enzyme Inhibitors/pharmacology , Female , Ferritins/metabolism , Glutathione/metabolism , Heme Oxygenase (Decyclizing)/antagonists & inhibitors , Heme Oxygenase-1 , Immunohistochemistry , Iron/metabolism , Lectins , Membrane Proteins , Metalloporphyrins/pharmacology , Mice , Mice, Inbred Strains , Multiple Sclerosis/metabolism , Multiple Sclerosis/pathology , Myelin Basic Protein/analysis , Nerve Fibers, Myelinated/chemistry , Nerve Fibers, Myelinated/enzymology , Nerve Fibers, Myelinated/pathology , Oxidative Stress , Protoporphyrins/pharmacology , T-Lymphocytes/cytology
11.
J Clin Microbiol ; 40(1): 239-46, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11773122

ABSTRACT

Since the associations between Helicobacter pylori genotype and disease differ in Asia and the West, we investigated the correlation between HP0638, encoding an outer membrane protein, and potential markers of virulence (cagA, vacA, and iceA). For 109 strains from nine countries, the status of cagA, vacA, and iceA was determined by PCR and/or a line probe assay. We also studied 18 strains from 8 patients (parents and 6 daughters) from a Dutch family and paired strains collected on average 8 years apart from 11 patients. When the HP0638 signal sequences were amplified by PCR and DNA sequence determinations were performed, 89 (96%) of 93 cagA-positive strains had HP0638 in frame, versus none (0%) of 16 cagA-negative strains (P < 0.001). Among strains in which HP0638 was in frame, a six-CT dinucleotide repeat pattern was dominant in Western countries (23 of 33 strains [70%]), while a pattern of three CT repeats with another CT after four T's (3 + 1-CT-repeat pattern) was dominant in East Asia (31 of 46 strains [67%]); however, specific CT repeat patterns did not correlate with clinical outcome. HP0638 phylogenetic trees also showed geographic characters. The HP0638 frame status and CT dinucleotide repeat patterns were identical for 9 of 11 pairs of strains obtained on average 8 years apart from individuals and the 15 strains obtained from the mother and all six daughters. Thus, HP0638 frame status and cagA status are strongly correlated. The CT dinucleotide repeat pattern in the putative HP0638 signal sequence has geographic characters and appears stable in particular patients and families over a period of years. Analysis of HP0638 CT polymorphisms may serve as a new typing system to discriminate H. pylori isolates for epidemiological purposes.


Subject(s)
Antigens, Bacterial , Bacterial Outer Membrane Proteins/genetics , Bacterial Proteins/metabolism , Helicobacter Infections/epidemiology , Helicobacter pylori/classification , Polymorphism, Genetic , Adult , Asia/epidemiology , Base Sequence , Colombia/epidemiology , Dinucleotide Repeats/genetics , Europe/epidemiology , Female , Helicobacter Infections/microbiology , Helicobacter pylori/genetics , Helicobacter pylori/metabolism , Helicobacter pylori/pathogenicity , Humans , Male , Molecular Sequence Data , Phylogeny , Sequence Analysis, DNA , Virulence/genetics
13.
J Neuroimmunol ; 119(2): 205-13, 2001 Oct 01.
Article in English | MEDLINE | ID: mdl-11585623

ABSTRACT

Multiple sclerosis (MS) and its animal model, experimental allergic encephalomyelitis (EAE), are autoimmune demyelinating diseases with autoreactive T-cells acting as important mediators of pathogenesis. Cuprizone, a copper chelator, and piperonyl butoxide (PBO), a pesticide synergist, are implicated to inhibit T-cell activation and function. The purpose of this study was to assess whether either of these agents would suppress PLP-peptide-induced EAE in the SJL mouse. Indeed, treatment with cuprizone beginning 1 week prior to disease induction, and PBO administration from days 1 to 9 of EAE, significantly attenuated EAE clinical severity. Furthermore, both agents decreased blood CD4+/CD8+ ratios, and reduced signs of chronic graft vs. host disease (GVHD) indicating attenuation of an immune T-cell response. These results suggest that cuprizone and PBO suppress EAE and use of these agents will provide insights into the mechanisms of T-cell mediated diseases.


Subject(s)
Chelating Agents/pharmacology , Cuprizone/pharmacology , Encephalomyelitis, Autoimmune, Experimental/immunology , Pesticide Synergists/pharmacology , Piperonyl Butoxide/pharmacology , T-Lymphocytes/immunology , Animals , CD4-CD8 Ratio , Chronic Disease , Encephalomyelitis, Autoimmune, Experimental/drug therapy , Female , Graft vs Host Disease/drug therapy , Graft vs Host Disease/immunology , Graft vs Host Disease/mortality , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Multiple Sclerosis/drug therapy , Multiple Sclerosis/immunology , Survival Rate , T-Lymphocytes/drug effects
14.
J Neurosci Res ; 65(4): 298-307, 2001 Aug 15.
Article in English | MEDLINE | ID: mdl-11494365

ABSTRACT

Bone marrow transplantation (BMT) has therapeutic value for twitcher (globoid cell leukodystrophy) mice, which suffer from a genetic deficiency of the lysosomal enzyme galactosylceramidase that leads to progressive demyelination and early death. Preliminary investigations indicated that a semiallogeneic BMT resulted in graft vs. host disease (GVHD) in twitcher mice but not normal mice. Increased production of the cytokine IL-6 has been demonstrated in twitcher mice, and it has been linked with induction of GVHD. We investigated the effects of BMT in twitcher/IL-6 deficient mice and compared these findings with those from transplanted twitcher and control mice. After a semiallogeneic BMT, 11.4% of controls died within few weeks while the rest survived >100 days without GVHD. In contrast, 85% of the transplanted twitcher mice died by 70 days and 65% developed clinical signs of GVHD, e.g., alopecia and weight loss. In transplanted twitcher/IL-6 deficient mice, only 21% died by Day 70, none had alopecia, and 23% had weight loss. There was no difference in the onset day and severity of twitching between twitcher and twitcher/IL-6 deficient mice after BMT. In transplanted twitcher/IL-6 deficient mice, there was improvement of BBB integrity and a decrease in globoid cell number compared with nontransplanted twitcher/IL-6 deficient mice. In summary, these results demonstrate that an underlying pathology like globoid cell leukodystrophy leads to activation of GVHD responses in a donor-host combination that would not normally induce GVHD. Furthermore, IL-6 seems to play a key role because a deficiency of IL-6 results in a better prognosis.


Subject(s)
Bone Marrow Transplantation/immunology , Interleukin-6/genetics , Leukodystrophy, Globoid Cell/immunology , Leukodystrophy, Globoid Cell/therapy , Minor Histocompatibility Antigens/immunology , Animals , Astrocytes/pathology , Blood-Brain Barrier , Body Weight , Brain/blood supply , Brain/immunology , Brain/pathology , Demyelinating Diseases/immunology , Demyelinating Diseases/pathology , Female , Gliosis/pathology , Graft vs Host Disease/genetics , Graft vs Host Disease/immunology , Graft vs Host Disease/pathology , Immunohistochemistry , Interleukin-6/immunology , Lectins , Leukodystrophy, Globoid Cell/mortality , Macrophages/pathology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Neurologic Mutants , Myelin Basic Protein/analysis , Serum Albumin/analysis , Serum Albumin/metabolism , Survival Rate , beta-Galactosidase/genetics
15.
J Heart Lung Transplant ; 20(8): 833-9, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11502405

ABSTRACT

BACKGROUND: At many lung transplant centers, right heart catheterization and transthoracic echocardiogram are part of the routine pre-transplant evaluation to measure pulmonary pressures. Because decisions regarding single vs bilateral lung transplant procedures and the need for cardiopulmonary bypass are often made based on pulmonary artery systolic pressures, we sought to examine the relationship between estimated and measured pulmonary artery systolic pressures using echocardiogram and catheterization, respectively. METHODS: We retrospectively reviewed all patients in our program who had measured pulmonary hypertension (n = 57). Patients with both echocardiogram-estimated and catheterization-measured pulmonary artery systolic pressures performed within 2 weeks of each other were included (n = 19). We analyzed results for correlation and linear regression in the entire group and in the patients with primary pulmonary hypertension (n = 8) and pulmonary fibrosis (n = 8). RESULTS: In patients with primary pulmonary hypertension, pulmonary artery systolic pressure was 94 +/- 27 and 95 +/- 15 mm Hg by echocardiogram and catheterization, respectively, with r(2) = 0.11; in patients with pulmonary fibrosis, 57 +/- 23 and 58 +/- 12 mm Hg with r(2) = 0.22; and in the whole group, 76 +/- 29 and 75 +/- 23 mm Hg with r(2) = 0.50. Thirty-two additional patients had mean pulmonary artery systolic pressure = 48 +/- 16 mm Hg by catheterization but either had no evidence of tricuspid regurgitation by echocardiogram (n = 22) or the pulmonary artery systolic pressure could not be measured (n = 10). CONCLUSIONS: In patients with pulmonary hypertension awaiting transplant, pulmonary artery systolic pressures estimated by echocardiogram correspond but do not serve as an accurate predictive model of pulmonary artery systolic pressures measured by catheterization. Technical limitations of the echocardiogram in this patient population often preclude estimating pulmonary artery systolic pressure.


Subject(s)
Cardiac Catheterization , Echocardiography, Doppler , Hypertension, Pulmonary/diagnosis , Lung Transplantation , Pulmonary Fibrosis/diagnosis , Pulmonary Wedge Pressure/physiology , Systole/physiology , Adult , Female , Humans , Hypertension, Pulmonary/physiopathology , Hypertension, Pulmonary/surgery , Male , Middle Aged , Pulmonary Fibrosis/physiopathology , Pulmonary Fibrosis/surgery , Retrospective Studies , Sensitivity and Specificity , Waiting Lists
16.
Best Pract Res Clin Rheumatol ; 15(2): 315-33, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11469824

ABSTRACT

Although the effectiveness of biological agents in systemic vasculitis is unproven, their introduction heralds a new era of vasculitis treatment. These agents offer the promise of targeted immunotherapies; the possibility of greater efficacy (and fewer side-effects) than conventional vasculitis treatments; and the potential to provide novel insights into the pathophysiology of these diseases-insights that may be gained only by using these agents in humans. Challenges to the investigation of these therapies in the systemic vasculitides exist, but important basic and clinical investigations are already in progress. We review the major issues facing the investigation of biological agents in vasculitis; examine the rationale for believing that biological strategies in vasculitis will be efficacious; identify several candidate targets for biological approaches; and discuss the results to date of early studies. The potential biological targets discussed include cytokines such as tumour necrosis factor; interleukins-1, -6, and -12; interferon-gamma; the co-stimulatory molecules B7-1 and B7-2; and others.


Subject(s)
Biological Products/therapeutic use , Immunoconjugates , Vasculitis/therapy , Abatacept , Animals , Antigens, CD/therapeutic use , Antigens, Differentiation/therapeutic use , B7-1 Antigen/therapeutic use , B7-2 Antigen , CTLA-4 Antigen , Cytokines/therapeutic use , Etanercept , Granulomatosis with Polyangiitis/therapy , Humans , Immunoglobulin G/therapeutic use , Immunotherapy , Interferon-gamma/therapeutic use , Interleukins/therapeutic use , Membrane Glycoproteins/therapeutic use , Receptors, Tumor Necrosis Factor/therapeutic use , Vasculitis/immunology
17.
J Comput Assist Tomogr ; 25(3): 417-24, 2001.
Article in English | MEDLINE | ID: mdl-11351193

ABSTRACT

PURPOSE: The purpose of this work was to investigate signs of subscapularis tendon tear on MRI. METHOD: Preoperative written interpretations of high field (n = 9) and low field (n = 7) MRI of 16 patients with tears confirmed at surgery or arthroscopy were reviewed, followed by retrospective review of these studies. RESULTS: A preoperative diagnosis of subscapularis tear was made in five (31%) cases. On retrospective review, primary signs of tear were present in 15 (94%) cases and in two-thirds were limited to the cranial third of the tendon. Supraspinatus tears were present in 69% of cases. Associated findings included medial dislocation (n = 4) or subluxation (n = 3) of biceps tendon, biceps tendinopathy (n = 2), superior labral tear (n = 5), and effusions of superior subscapularis recess (n = 6), subcoracoid bursa (n = 2), or both (n = 5). One or more associated signs were present in 94% of cases. CONCLUSION: Subscapularis tear is frequently missed on MRI. Recognizing that primary signs of tear may be limited to the cranial third of the subscapularis tendon and identifying associated signs should facilitate diagnosis.


Subject(s)
Magnetic Resonance Imaging , Rotator Cuff Injuries , Tendon Injuries/diagnosis , Adult , Aged , Chi-Square Distribution , Female , Humans , Male , Middle Aged , Retrospective Studies , Rotator Cuff/pathology , Tendon Injuries/pathology
18.
J Neurochem ; 75(6): 2555-62, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11080209

ABSTRACT

Oxidative stress is implicated in the pathogenesis of experimental allergic encephalomyelitis (EAE), a model for multiple sclerosis. Heme oxygenase-1 (HO-1) is a heat shock protein induced by oxidative stress. HO-1 metabolizes the pro-oxidant heme to the antioxidant biliverdin and CO. HO-1 requires electrons, donated by NADPH cytochrome P450 reductase (henceforth, reductase), for catalytic activity. EAE was induced with a peptide of proteolipid protein in SJL mice, and the expression of HO-1 and reductase in the hindbrain was analyzed. HO-1 protein levels were significantly increased in EAE animals compared with control mice. HO-1 expression was present in ameboid macrophages, reactive microglia, and astrocytes in white matter tracks. Bergmann glia and ameboid macrophages also were occasionally stained in the molecular layer of the cerebellum. Unlike HO-1, reductase protein levels decreased with disease severity. HO-1 and reductase were associated with each other in endoplasmic reticulum micelles, suggesting that the decrease in reductase does not interfere with its association with HO-1. In cells that express HO-1, the association of reductase with HO-1 should competitively inhibit the interaction of reductase with cytochrome P450 isozymes and thereby limit free radical production as the latter two enzymes act cooperatively to produce superoxide. The increase in HO-1 together with the decrease in reductase may be part of a common defense mechanism attempting to minimize tissue damage in several neurological conditions.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/enzymology , Heme Oxygenase (Decyclizing)/biosynthesis , Leukodystrophy, Globoid Cell/enzymology , NADPH-Ferrihemoprotein Reductase/biosynthesis , Animals , Blotting, Western , Cerebellum/enzymology , Female , Heme Oxygenase-1 , Immunohistochemistry , Medulla Oblongata/enzymology , Membrane Proteins , Mice , Mice, Inbred Strains , Mice, Neurologic Mutants , Microsomes/enzymology , Oxidative Stress/physiology , Pons/enzymology
19.
J Neuroimmunol ; 110(1-2): 186-94, 2000 Oct 02.
Article in English | MEDLINE | ID: mdl-11024549

ABSTRACT

Twitcher mice have an autosomal recessive mutation in the gene for the lysosomal enzyme galactosylceramidase, which is the same gene that is affected in human globoid cell leukodystrophy (Krabbe's disease). The failure to digest galactosylceramide and psychosine leads to initial pathological changes in oligodendrocytes. Secondary pathological changes that include infiltrating macrophages and other inflammatory responses have been postulated to promote the disease course. TNFalpha levels are elevated in twitcher mice compared to control animals, and studies on another demyelinating disease, experimental allergic encephalomyelitis, indicate that TNF promotes pathogenesis via TNF-receptor 1 (TNF-R1). In the present study, twitcher/TNF-R1 deficient mice were generated, and the clinical and pathological course was compared between these mice and regular twitcher mice. There was no statistical evidence for any differences between these two groups of mice for all clinical (life span, weight loss, onset day of twitching) and pathological (demyelination, astrocyte gliosis, macrophage infiltration) measures that were examined. If mice were administered an intraperitoneal injection of LPS, then twitcher/TNF-R1 deficient mice had a longer [corrected] life span and a decreased [corrected] disruption to the blood-brain barrier compared to regular twitcher mice. These results showed that TNF-R1 is not sufficiently activated to affect the pathological and/or clinical signs during the natural course of this disease. However, when there is a secondary insult, TNF-R1 activation does lead to a significant acceleration of the development of clinical and pathological signs.


Subject(s)
Leukodystrophy, Globoid Cell/immunology , Leukodystrophy, Globoid Cell/pathology , Lipopolysaccharides/pharmacology , Receptors, Tumor Necrosis Factor/genetics , Animals , Blood-Brain Barrier/immunology , Brain/immunology , Brain/pathology , Demyelinating Diseases/genetics , Demyelinating Diseases/immunology , Demyelinating Diseases/pathology , Disease Models, Animal , Galactosylceramidase/genetics , Immune System/drug effects , Immune System/immunology , Leukodystrophy, Globoid Cell/genetics , Lysosomes/enzymology , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Neurologic Mutants , Oligodendroglia/immunology , Oligodendroglia/pathology , Organ Size , Receptors, Tumor Necrosis Factor/immunology , Sciatic Nerve/immunology , Sciatic Nerve/pathology
20.
Cell Mol Biol (Noisy-le-grand) ; 46(3): 663-72, 2000 May.
Article in English | MEDLINE | ID: mdl-10872753

ABSTRACT

Oxidative stress is thought to be an important pathogenic mechanism in many diseases of the retina. The purpose of this study was to investigate the chemical changes that are present in the photoreceptor outer segments of the retina following exposure to oxidative stress. Fourier transform infrared (FT-IR) microspectroscopy enables the characterization and semi-quantitation of chemical functional groups in microscopic regions of tissue sections. This technique was used to evaluate the chemical changes in the outer segments following exposure to ferrous sulfate, which promotes oxidative tissue damage. A reduction of C=C-H and C=O functional groups was observed in the outer segments of iron-injected eyes compared to vehicle-injected eyes at 3 days following injection, which is prior to major histological changes that occur by 7 days. These functional groups are found in docosahexaenoic acid (DHA), which is present at a high concentration in the outer segments. DHA contains a series of six cis-conjugated double bonds, which are vulnerable to free radical attack, and the reduction of these unsaturation group absorptions suggests that DHA was degraded and/or removed from the outer segments. An unexpected finding was that several other chemical functional groups increased in concentration over time in the outer segments of vehicle-injected eyes compared to non-injected eyes. These increases generally did not include C=C-H or C=O, which suggests that either DHA was being degraded while other organic molecules were being concentrated, or that production of DHA failed to be upregulated in vehicle-injected eyes. In summary, there was a loss of both C=C-H and C=O functional group concentrations in the outer segments of iron-injected eyes, and there was an increased concentration of several other chemical functional groups following trauma induced by vehicle injection.


Subject(s)
Iron/metabolism , Oxidative Stress , Rod Cell Outer Segment/metabolism , Animals , Ferrous Compounds/administration & dosage , Ferrous Compounds/metabolism , Injections , Iron/administration & dosage , Rats , Rats, Long-Evans , Rod Cell Outer Segment/ultrastructure , Sodium Chloride/administration & dosage , Spectroscopy, Fourier Transform Infrared/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...